August 23, 2016
The Japan unit of GlaxoSmithKline said on August 22 that it made payments totaling 6.23 billion yen to medical institutions and healthcare professionals in 2015. GSK spent 3.53 billion yen in R&D expenditures including trial costs, and nearly 428 million...read more